These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19209421)

  • 1. Editorial comment on: current applications for prostate-specific antigen doubling time.
    Gallina A; Karakiewicz PI
    Eur Urol; 2008 Aug; 54(2):302. PubMed ID: 19209421
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: current applications for prostate-specific antigen doubling time.
    Semjonow A
    Eur Urol; 2008 Aug; 54(2):301. PubMed ID: 19209420
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: current applications for prostate-specific antigen doubling time.
    O'Brien MF
    Eur Urol; 2008 Aug; 54(2):300-1. PubMed ID: 19209419
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Carter HB
    J Urol; 2010 Jan; 183(1):116-7. PubMed ID: 19913815
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Connolly D
    J Urol; 2010 Jan; 183(1):117. PubMed ID: 19913813
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
    Froehner M
    Eur Urol; 2008 Aug; 54(2):368-9. PubMed ID: 18006213
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
    Stephan C; Jung K
    Eur Urol; 2008 Aug; 54(2):369-70. PubMed ID: 18006212
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
    Shimbo M
    Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Loeb S
    Urology; 2015 Jan; 85(1):170-1. PubMed ID: 25530380
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Loeb S
    J Urol; 2011 Mar; 185(3):826-7. PubMed ID: 21239022
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
    Bañez LL
    Urology; 2010 Nov; 76(5):e4. PubMed ID: 21056250
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial Comment.
    Hoimes CJ; Madabhushi A
    Urology; 2016 Feb; 88():132-3. PubMed ID: 26964790
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment.
    Carter HB
    Urology; 2009 Jul; 74(1):183; aurhor reply 183-4. PubMed ID: 19567300
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Krieger JN
    J Urol; 2010 Mar; 183(3):944-5; discussion 945. PubMed ID: 20089278
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Baltaci S
    J Urol; 2010 Mar; 183(3):944; discussion 945. PubMed ID: 20089266
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
    Autorino R; Perdonà S; Di Lorenzo G
    Urology; 2010 Nov; 76(5):1076; author reply 1076-7. PubMed ID: 21056255
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Methods of calculating prostate-specific antigen velocity.
    Eggener S
    Eur Urol; 2007 Oct; 52(4):1050-1. PubMed ID: 17933029
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
    Philip J
    Eur Urol; 2008 May; 53(5):981-2. PubMed ID: 17997013
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment.
    Gardiner RA
    J Urol; 2009 Nov; 182(5):2121; discussion 2122. PubMed ID: 19758653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.